Who owns CANDEL THERAPEUTICS, INC?
- Ticker: CADL
- CUSIP Number: 137404109
Tip: Access positions for across all investors
Analyze quarterly positions in Candel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Candel Therapeutics stock
Who bought or sold CANDEL THERAPEUTICS, INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Northpond Ventures | 1.9M | $13M | 0% | Sep 2024 |
|
| BlackRock | 1.1M | $7.8M | 100% | Sep 2024 |
|
| BlackRock | 823k | $5.1M | 1630% | Jun 2024 |
|
| Vanguard Group | 819k | $5.1M | 51% | Jun 2024 |
|
| State Street Corporation | 473k | $2.9M | 1613% | Jun 2024 |
|
| Geode Capital Management | 449k | $3.1M | 13% | Sep 2024 |
|
| Sands Capital Ventures | 406k | $2.8M | -50% | Sep 2024 |
|
| Nuveen Asset Management | 382k | $2.4M | 100% | Jun 2024 |
|
| Susquehanna International | 224k | $1.5M | 247% | Sep 2024 |
|
| Northern Trust | 159k | $1.1M | 714% | Sep 2024 |
|
| Citadel Advisors | 111k | $767k | 49% | Sep 2024 |
|
| Bridgeway Capital Management | 81k | $500k | -2% | Jun 2024 |
|
| Jane Street | 73k | $505k | 509% | Sep 2024 |
|
| HB Wealth Management | 57k | $393k | 100% | Sep 2024 |
|
| Charles Schwab Investment Management | 47k | $324k | 0% | Sep 2024 |
|
| Bank of New York Mellon | 45k | $312k | -17% | Sep 2024 |
|
| Barclays | 29k | $199k | 327% | Sep 2024 |
|
| Simplex Trading | 23k | $158k | 357% | Sep 2024 |
|
| Virtu Financial | 23k | $140k | 100% | Jun 2024 |
|
| Rhumbline Advisers | 23k | $156k | -2% | Sep 2024 |
|
| Mml Investors Services | 22k | $155k | -70% | Sep 2024 |
|
| Vontobel Holding | 22k | $153k | 0% | Sep 2024 |
|
| Bank of America Corporation | 22k | $152k | -60% | Sep 2024 |
|
| AQR Capital Management | 20k | $139k | 100% | Sep 2024 |
|
| Morgan Stanley | 20k | $121k | 100% | Jun 2024 |
|
| Alpine Partners VI | 19k | $116k | 100% | Jun 2024 |
|
| Goldman Sachs Group | 18k | $113k | 100% | Jun 2024 |
|
| Citigroup | 15k | $100k | 215% | Sep 2024 |
|
| MetLife Investment Advisors | 13k | $87k | 100% | Sep 2024 |
|
| Squarepoint Ops | 12k | $76k | 100% | Jun 2024 |
|
| Janney Montgomery Scott | 12k | $81k | 0% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 11k | $75k | 100% | Sep 2024 |
|
| Alliancebernstein | 11k | $66k | 100% | Jun 2024 |
|
| Jpmorgan Chase & Co | 9.1k | $63k | -53% | Sep 2024 |
|
| Wells Fargo & Company | 6.2k | $43k | -2% | Sep 2024 |
|
| Royal Bank of Canada | 2.8k | $19k | 25% | Sep 2024 |
|
| Summit Investment Advisors | 1.9k | $14k | 0% | Sep 2024 |
|
| New York State Common Retirement Fund | 1.7k | $12k | -90% | Sep 2024 |
|
| California State Teachers Retirement System | 1.4k | $10k | 0% | Sep 2024 |
|
| Tower Research Capital | 1.3k | $7.8k | -66% | Jun 2024 |
|
| Amalgamated Bank | 686.00 | $5.0k | 0% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 533.00 | $3.7k | 684% | Sep 2024 |
|
| NISA Investment Advisors | 78.00 | $541.000200 | 100% | Sep 2024 |
|
| CWM | 41.00 | $0 | 100% | Sep 2024 |
|
| GAMMA Investing | 29.00 | $200.999000 | 100% | Sep 2024 |
|
| Sterling Capital Management | 20.00 | $139.000000 | 100% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 3.00 | $21.000000 | 100% | Sep 2024 |
|
Who sold out of Candel Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cubist Systematic Strategies | Jun 2024 | 26k | $162k |
| Schonfeld Strategic Advisors | Jun 2024 | 22k | $133k |
| Renaissance Technologies | Jun 2024 | 21k | $128k |
| Millennium Management | Jun 2024 | 17k | $108k |
| Two Sigma Investments | Mar 2024 | 13k | $21k |
| Point72 | Jun 2024 | 4.9k | $31k |
| Point72 Asia | Jun 2024 | 813.00 | $5.0k |